Incidencia y características clínicas de las neumonías tratadas ambulatoriamente en las personas mayores de 65 años del área de Tarragona-Valls, 2002-2005

Vila-Córcoles, Ángel; Blanco, Teresa Rodríguez; Ochoa-Gondar, Olga; Serrano, Elisabet Salsench; Diego-Cabanes, Cinta de; López, Amparo Valdivieso

doi:10.1590/s1135-57272009000200014

Cited by 2 publications

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Previous studies have examined the significance of ambulatory CAP in the Spanish adult population. A prospective epidemiological study that analyzed the incidence of both hospitalized and ambulatory CAP in adults in the north-east region of Spain during 2002-2005 reported an annual incidence of 2.6 cases per 1000 elderly persons [13], while a study by Aramburu et al found an incidence rate of 8.3 cases per 1000 inhabitants and year in the population > 14 years in the north of Spain (Gipuzkoa) [11]. Our results are based on the incidence data of four of the participating primary care centers with average rates ranging from 1.2 to 3.5 cases per 1000 persons per year, with a mean of 2.1 cases per 1000 persons per year.…”

Section: Discussionmentioning

confidence: 99%

CAPPRIC Study—Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings

Molina

González-Gamarra

Ginel³

et al. 2021

Microorganisms

View full text Add to dashboard Cite

The real burden of community-acquired pneumonia (CAP) in non-hospitalized patients is largely unknown. This is a 3-year prospective, observational study of ambulatory CAP in adults, conducted in 24 Spanish primary care centers between 2016–2019. Sociodemographic and clinical variables of patients with radiographically confirmed CAP were collected. Pneumococcal etiology was assessed using the Binax Now® test. Patients were followed up for 10 ± 3 days. A total of 456 CAP patients were included in the study. Mean age was 56.6 (±17.5) years, 53.5% were female, and 53.9% had ≥1 comorbidity. Average incidence of CAP was 1.2–3.5 cases per 1000 persons per year. Eighteen patients (3.9%) were classified as pneumococcal CAP. Cough was present in 88.1% of patients at diagnosis and fever in 70.8%. Increased pulmonary density (63.3%) and alveolar infiltrates with air bronchogram (16.6%) were the most common radiographic findings. After 14.6 ± 6.0 days (95% CI = 13.9–15.3), 65.4% of patients had recovered. Hospitalization rate was 2.8%. The most frequently prescribed antibiotics were quinolones (58.7%) and β-lactams (31.1%). In conclusion, one-third of CAP patients did not fully recover after two weeks of empiric antibiotic therapy and 2.8% required hospitalization, highlighting the significant burden associated with non-hospitalized CAP in Spain.

show abstract

Section: Discussionmentioning

confidence: 99%

CAPPRIC Study—Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings

Molina

González-Gamarra

Ginel³

et al. 2021

Microorganisms

View full text Add to dashboard Cite

show abstract

“…Vila-Corcoles en (21) España observó una alta mortalidad y complicaciones en pacientes mayores de 50 años, también relacionadas con la presencia de comorbilidades . La frecuencia (22,23) respiratoria elevada, la presencia de disnea y la menor saturación de oxígeno se asociaron con una menor probabilidad de evolución favorable, pero un mayor riesgo de presentar secuelas respiratorias y fallecer.…”

Section: Pg 95unclassified

Hiperglicemia al ingreso hospitalario como predictor de mala evolución en pacientes hospitalizados por COVID-19

Cuba Ticona,

Indacochea Cáceda

2024

RFMH

View full text Add to dashboard Cite

Introducción: La hiperglicemia al ingreso hospitalario podría ser una buena herramienta para predecir evolución desfavorable en pacientes con COVID-19. Objetivo: Determinar si la hiperglicemia al ingreso hospitalario constituye un factor pronóstico de evolución desfavorable. Métodos: Se realizó un estudio observacional, analítico, de cohorte retrospectivo en el Hospital Regional de Moquegua. Se revisaron de manera aleatoria historias clínicas de 640 pacientes hospitalizados con COVID-19 confirmado durante las primeras dos olas de la pandemia. Las variables incluyeron evolución desfavorable, secuelas respiratorias, ingreso a la Unidad de Cuidados Intensivos (UCI), y fallecimiento. La hiperglicemia al ingreso se definió como glicemia >140 mg/dL. Se realizaron análisis bivariados y multivariados utilizando modelos de regresión de Poisson con varianzas robustas para hallar el riesgo relativo crudo y ajustado (RRa) con sus respectivos IC95%. Resultados: El 36,9% tuvo 60 o más años, el 58,9% fue del sexo masculino y el 10,2% tuvo diabetes mellitus. El 34,7% de los pacientes presentaron hiperglicemia al ingreso. La hiperglicemia se asoció significativamente con una evolución desfavorable (RRa = 5,65; IC95%: 3,72-8,62; p < 0,001), secuelas respiratorias (RRa = 1,96; IC95%: 1,74-2,21; p < 0,001), ingreso a UCI (RRa = 3,68; IC95%: 2,03-6,69; p < 0,001), y fallecimiento (RRa = 1,57; IC95%: 1,22-2,02; p = 0,001). Conclusión: La hiperglicemia al ingreso es un factor pronóstico significativo para evolución desfavorable en pacientes con COVID-19. Es esencial monitorear cuidadosamente a estos pacientes.

show abstract

Incidencia y características clínicas de las neumonías tratadas ambulatoriamente en las personas mayores de 65 años del área de Tarragona-Valls, 2002-2005

Cited by 2 publications

References 28 publications

CAPPRIC Study—Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings

CAPPRIC Study—Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings

Hiperglicemia al ingreso hospitalario como predictor de mala evolución en pacientes hospitalizados por COVID-19

Contact Info

Product

Resources

About